Onward CEO Dave Marver expressed optimism about the therapy’s potential, stating, “If the therapy continues to show promise, it is possible it could reach patients by the end of the decade.” Importantly, Onward aims to expedite the commercialization of its external spinal cord stimulation solution, ARC-EX Therapy, to restore hand and arm function, with a targeted release in the second half of 2024.
Onward Medical is part of a growing field of BCI-based startups that are harnessing this emerging technology to address various medical conditions. Their applications encompass limb loss, self-regulatory function recovery post-stroke or spinal cord injury, physical rehabilitation, and communication assistance for individuals with Locked-In Syndrome. The transformative potential of brainwave-driven implants offers a glimpse into a future where medical breakthroughs redefine the boundaries of possibility in healthcare.
